Related Experiment Videos
[HIV resistance. More the rule than an exception]
M Oette1, R Kaiser, D Häussinger
1Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf. oettem@med.uni-duesseldorf.de
MMW Fortschritte Der Medizin
|March 12, 2004
Summary
HIV resistance mutations frequently cause treatment failure. Understanding HIV drug resistance in both treated and untreated patients is crucial for effective HIV infection management and guides resistance testing strategies.
Area of Science:
- Virology
- Infectious Diseases
- Genetics
Context:
- Highly active antiretroviral therapy (HAART) is a cornerstone of HIV management.
- Emergence of drug-resistant HIV strains poses a significant challenge to treatment efficacy.
- Studies indicate a substantial prevalence of resistance-associated mutations in HIV-infected individuals.
Purpose:
- To highlight the prevalence and impact of HIV resistance mutations.
- To underscore the importance of resistance testing in managing HIV infection.
- To inform clinical practice regarding rational use of antiretroviral therapy.
Summary:
- Resistance-associated mutations in the human immunodeficiency virus (HIV) genome are a primary cause of HAART failure.
- Data from HCUS-study show resistant strains in ~50% of cases, with ~80% of therapy failures linked to resistance.
- Resistance is also observed in treatment-naive patients (e.g., 12% in German Seroconverter Study), indicating a widespread issue.
Impact:
- The widespread distribution of HIV resistance necessitates a rational approach to resistance testing.
- Findings emphasize the need for ongoing research and international collaboration to address HIV resistance.
- Effective management of HIV infection relies on understanding and monitoring drug resistance patterns.